These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37567466)

  • 41. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
    Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
    Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intensive patient's care program reduces anxiety and depression as well as improves overall survival in
    Bao H; Chen Y; Li M; Pan L; Zheng X
    Transl Cancer Res; 2019 Feb; 8(1):212-227. PubMed ID: 35116750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Home-based multidimensional survivorship programmes for breast cancer survivors.
    Cheng KKF; Lim YTE; Koh ZM; Tam WWS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anxiety, depression and quality of life in colorectal cancer patients.
    Tsunoda A; Nakao K; Hiratsuka K; Yasuda N; Shibusawa M; Kusano M
    Int J Clin Oncol; 2005 Dec; 10(6):411-7. PubMed ID: 16369745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy.
    Papadopoulou A; Govina O; Tsatsou I; Mantzorou M; Mantoudi A; Tsiou C; Adamakidou T
    Med Pharm Rep; 2022 Oct; 95(4):418-429. PubMed ID: 36506609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of life, anxiety, and depression in Turkish colorectal cancer patients.
    Alacacioglu A; Binicier O; Gungor O; Oztop I; Dirioz M; Yilmaz U
    Support Care Cancer; 2010 Apr; 18(4):417-21. PubMed ID: 19554353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of a novel designed intensive patient care program on cognitive impairment, anxiety, depression as well as relapse free survival in acute ischemic stroke patients: a randomized controlled study.
    Yu HL; Cao DX; Liu J
    Neurol Res; 2019 Sep; 41(9):857-866. PubMed ID: 31266412
    [No Abstract]   [Full Text] [Related]  

  • 50. Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice.
    Lorusso D; Colombo N; Herraez AC; Santin AD; Colomba E; Miller DS; Fujiwara K; Pignata S; Baron-Hay SE; Ray-Coquard IL; Shapira-Frommer R; Kim YM; McCormack M; Massaad R; Nguyen AM; Zhao Q; McKenzie J; Prabhu VS; Makker V
    Eur J Cancer; 2023 Jun; 186():172-184. PubMed ID: 37086595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinically Important Reductions in Physical Function and Quality of Life in Adults with Tumor Prostheses in the Hip and Knee: A Cross-sectional Study.
    Fernandes L; Holm CE; Villadsen A; Sørensen MS; Zebis MK; Petersen MM
    Clin Orthop Relat Res; 2021 Oct; 479(10):2306-2319. PubMed ID: 33974591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a nurse-led management program to complement the treatment of adolescent acute lymphoblastic leukemia patients.
    Lin H; Zhou S; Zhang D; Huang L
    Appl Nurs Res; 2016 Nov; 32():e1-e5. PubMed ID: 27595414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Responses of lung cancer survivors undergoing gamma knife surgery to supportive group psychotherapy.
    Peng W; Zhang H; Li Z
    Medicine (Baltimore); 2019 Mar; 98(9):e14693. PubMed ID: 30817604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
    Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA
    J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
    Franken MD; de Hond A; Degeling K; Punt CJA; Koopman M; Uyl-de Groot CA; Versteegh MM; van Oijen MGH
    Health Qual Life Outcomes; 2020 Jul; 18(1):240. PubMed ID: 32690011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Home-based psychological nursing interventions for improvement of sleep quality and psychological health in patients with hypopharyngeal carcinoma undergoing surgical resections: a randomized trial.
    Li X; Chen L; Lei B; Xie C
    Ann Palliat Med; 2021 Dec; 10(12):12347-12357. PubMed ID: 35016426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
    Rischin D; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Braña I; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Ishak WZW; Hong RL; Mendoza RG; Jia L; Chirovsky D; Norquist J; Jin F; Burtness B
    Oral Oncol; 2022 May; 128():105815. PubMed ID: 35381576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.